Binding of Ligands and Activation of Transcription by Nuclear Receptors
- 1 June 2001
- journal article
- review article
- Published by Annual Reviews in Annual Review of Biophysics and Biophysical Chemistry
- Vol. 30 (1), 329-359
- https://doi.org/10.1146/annurev.biophys.30.1.329
Abstract
▪ Abstract Nuclear receptors (NRs) form a superfamily of ligand-inducible transcription factors composed of several domains. Recent structural studies focused on domain E, which harbors the ligand-binding site and the ligand-dependent transcription activation function AF-2. Structures of single representatives in an increasing number of various complexes as well as new structures of further NRs addressed issues such as discrimination of ligands, superagonism, isotype specificity, and partial agonism. Until today, one unique transcriptionally active form of domain E was determined; however, divergent tertiary structures of apo-forms and transcriptionally inactive forms are known. Thus, recent results link the transformation of NRs upon ligand binding to principles of protein folding. Furthermore, the ensemble of NR structures, including those of DNA-binding domains, provides one of the foundations for the understanding of interactions with transcription intermediary factors up to the characterization of the link between NR complexes and the basal transcriptional machinery at the structural level.Keywords
This publication has 66 references indexed in Scilit:
- Structural basis for isotype selectivity of the human retinoic acid nuclear receptorJournal of Molecular Biology, 2000
- Ligand-induced stabilization of PPARγ monitored by NMR spectroscopy: implications for nuclear receptor activationJournal of Molecular Biology, 2000
- Molecular determinants of nuclear receptor-corepressor interactionGenes & Development, 1999
- Retinoic acid receptor: a simulation analysis of retinoic acid binding and the resulting conformational changesJournal of Molecular Biology, 1999
- Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- NEWVSOLD FASHIONED OESTRADIOL ANTAGONISTS IN MAMMARY CARCINOMA: `IN VITRO' AND `IN VIVO' PHARMACOLOGICAL APPROACHESPharmacological Research, 1999
- Slit Branches Out: A Secreted Protein Mediates Both Attractive and Repulsive Axon GuidanceCell, 1999
- p300 Interacts with the N- and C-terminal Part of PPARγ2 in a Ligand-independent and -dependent Manner, RespectivelyPublished by Elsevier BV ,1999
- The RXR heterodimers and orphan receptorsCell, 1995
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995